DAIICHI SANKYO COMPANY, LIMITED

4568・Prime Market・Pharmaceuticals

Official website

DAIICHI SANKYO COMPANY, LIMITED

4568・Prime Market・Pharmaceuticals

Official website

DAIICHI SANKYO COMPANY, LIMITED4568

Reference Indicators

Market Cap

53,269¥100M

P/E (Forecast)

19.7x

P/B

3.1x

Dividend Yield (Forecast)

3.56%

ROE

15.6%

EV/EBITDA

15.9x

Financial Summary

Unit: ¥M

Item	2022Mar 2022	2023Mar 2023	2024Mar 2024	2025Mar 2025	2026Mar 2026
Net Sales	1,044,892	1,278,478	1,601,688	1,886,256	2,123,045
Cost of Sales	353,328	363,525	415,322	415,797	669,045
Gross Profit	691,563	914,952	1,186,366	1,470,458	1,454,000
SG&A Expenses	358,309	471,221	636,997	731,200	780,683
Operating Income	73,025	120,580	211,588	331,925	229,089
Pre-tax Income	73,516	126,854	237,234	355,631	263,432
Income Taxes	6,543	17,666	36,217	59,874	3,558
Net Income	66,972	109,188	200,731	295,756	259,874
EBITDA	131,270	188,369	271,234	400,574	306,549
Gross Margin	66.2%	71.6%	74.1%	78.0%	68.5%
Operating Margin	7.0%	9.4%	13.2%	17.6%	10.8%
ROA	3.0%	4.4%	5.8%	8.6%	6.5%
ROE	5.0%	7.6%	11.9%	18.2%	15.6%